Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function.
We compared predictive values of anti-Müllerian hormone (AMH) and baseline FSH with respect to IVF cycle outcomes based on oocyte numbers retrieved and number of clinical pregnancies established. In 76 IVF cycles investigated, AMH was clearly superior in predicting IVF outcomes in comparison with FSH.
Barad
David H
DH
Center for Human Reproduction, New York, New York 10021, USA. dbarad@thechr.com
Weghofer
Andrea
A
Gleicher
Norbert
N
D000293:Adolescent; D000328:Adult; D054304:Anti-Mullerian Hormone / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D004967:Estrogens / Q000097:blood; D005260:Female; D005307:Fertilization in Vitro / Q000379:methods; D005640:Follicle Stimulating Hormone / Q000097:blood*; D006801:Humans; D008875:Middle Aged; D054315:Oocyte Retrieval / Q000379:methods*; D010053:Ovary / Q000502:physiology*; D011237:Predictive Value of Tests; D011247:Pregnancy; D011256:Pregnancy Outcome; D018873:Pregnancy Rate; D012044:Regression Analysis; D012189:Retrospective Studies; D012680:Sensitivity and Specificity; D055815:Young Adult
D015415:Biomarkers; D004967:Estrogens; D054304:Anti-Mullerian Hormone; D005640:Follicle Stimulating Hormone